Johnson & Johnson closed $22.62 below its 52-week high ($168.85), which the company achieved on September 4th.
Discover why JNJ's long-term buy rating is supported by its blue-chip status, profitability, and diverse revenue lines, ...
Johnson & Johnson closed $25.19 below its 52-week high ($168.85), which the company reached on September 4th.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback